Robert V JR Gunderson
CIK 1302450 · last filed 2026-05-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.07M
Companies
4
Total Filings
22
Lifetime Open-Market Net
$286.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ANDG | Director | 15,000 | $49.00 | $735.0K | $286.9K | 2 | 2026-05-22 |
| TBPH | Director | 78,940 | $16.92 | $1.34M | $0 | 7 | 2021-04-29 |
| Vitae Pharmaceuticals, Inc (VTAE) Delisted | Director | 0 | — | — | $0 | 5 | 2016-10-25 |
| Innoviva, Inc. (THRX) Delisted | Director | 89,873 | $4.06 | $364.9K | $0 | 8 | 2013-04-26 |
Recent Filings · Page 2 of 3
22 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-06-01 | Vitae Pharmaceuticals, Inc (VTAE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-04-24 | TBPH | Grant (A) | +6,000 | $0 | EDGAR |
| 2014-10-01 | Vitae Pharmaceuticals, Inc (VTAE) Delisted | Conv (C) | +11,002 | $0 | EDGAR |
| 2014-09-26 | Vitae Pharmaceuticals, Inc (VTAE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-04-26 | Innoviva, Inc. (THRX) Delisted | Grant (A) | +6,000 | $0 | EDGAR |
| 2012-05-17 | Innoviva, Inc. (THRX) Delisted | Grant (A) | +6,000 | $0 | EDGAR |
| 2011-04-28 | Innoviva, Inc. (THRX) Delisted | Grant (A) | +6,000 | $0 | EDGAR |
| 2010-12-27 | Innoviva, Inc. (THRX) Delisted | Other (J) | +768 | $0 | EDGAR |
| 2010-04-28 | Innoviva, Inc. (THRX) Delisted | Grant (A) | +6,000 | $0 | EDGAR |
| 2009-04-24 | Innoviva, Inc. (THRX) Delisted | Grant (A) | +6,000 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.